尼罗替尼及其中间体

尼罗替尼及其中间体

Nilotinib & its intermediates

641571-10-0

C₂₈H₂₂F₃N₇O

529.5158

4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺; 尼罗替尼; 尼罗替尼及其中间体(研发); 4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺

Nilotinib; AMN 107; Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-; 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide Nilotinib(TINIBS ); Nilotinib for research; Tasigna; Nilotinib & its intermediates (Developing); Nilotinib, AMN107, Tasigna; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide

-

1.362g/cm³

-

-

-

-